Subscribe To Our Free Newsletter |
Divis Lab Q4 PAT spurts 68% YoY; declares dividend of Rs 30/share
The pharma major's consolidated net profit jumped 67.6% to Rs 538 crore on 18.04% rise in revenue from operations to Rs 2,303 crore in Q4 FY24 over Q4 FY23.